Who backs Linnaeus Therapeutics?
8 investors| Investor | Type |
|---|---|
| Springboard Enterprises | Other |
| Kairos Ventures | — |
| National Cancer Institute | — |
| National Institute for Allergy and Infectious Disease | — |
| Penn Center for Innovation | — |
| Penn Medicine Co-Investment Program | — |
| UNM Rainforest Innovations | — |
| University of Pennsylvania | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Linnaeus Therapeutics investors
8 investors are on record for Linnaeus Therapeutics, including Springboard Enterprises, Kairos Ventures, National Cancer Institute and National Institute for Allergy and Infectious Disease. The seed round in Feb 2026 drew 26 investors.
Free account
More of Linnaeus Therapeutics with a free account
- ·Watch Linnaeus Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 8 firms already write checks for companies like Linnaeus Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View